Tafinlar/Mekinist (dabrafenib/trametinib)
pCPA File Number:
20935
Negotiation Status:
Negotiations were not pursued
Indication(s):
Non-Small Cell Lung Cancer (with CNS metastases)
Sponsor/Manufacturer:
Novartis Pharmaceuticals Canada Inc.
CDA-AMC Project Number:
PC0106-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: